Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiromic Biopharma, Inc. (KRBP)
:KRBP
Holding KRBP?
Track your performance easily
KRBP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.75 - $3.78
Previous CloseN/A
Volume1.00
Average Volume (3M)1.14K
Market Cap
$1.45M
Enterprise Value$13.62M
Total Cash (Recent Filing)$384.30K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.43
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.61
Shares Outstanding1,545,920
10 Day Avg. Volume473
30 Day Avg. Volume1,138
Standard Deviation0.47
R-Squared0.03
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap9.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kiromic Biopharma News
PremiumCompany Announcements
Kiromic BioPharma’s Strategic Financial Restructuring and Equity Shift
PremiumCompany Announcements
Kiromic Biopharma Outlines Vision in Stakeholder MeetingsOptions Prices
Currently, No data available
---
Ownership Overview
19.72% Insiders
―
Mutual Funds
― Other Institutional Investors
80.28% Public Companies and
Individual Investors
KRBP FAQ
What was Kiromic Biopharma, Inc.’s price range in the past 12 months?
Kiromic Biopharma, Inc. lowest stock price was $0.75 and its highest was $3.78 in the past 12 months.
What is Kiromic Biopharma, Inc.’s market cap?
Kiromic Biopharma, Inc.’s market cap is $1.45M.
When is Kiromic Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kiromic Biopharma, Inc.’s earnings last quarter?
Kiromic Biopharma, Inc. released its earnings results on May 12, 2023. The company reported -$6.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.17.
Is Kiromic Biopharma, Inc. overvalued?
According to Wall Street analysts Kiromic Biopharma, Inc.’s price is currently Overvalued.
Does Kiromic Biopharma, Inc. pay dividends?
Kiromic Biopharma, Inc. does not currently pay dividends.
What is Kiromic Biopharma, Inc.’s EPS estimate?
Kiromic Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kiromic Biopharma, Inc. have?
Kiromic Biopharma, Inc. has 1,545,920 shares outstanding.
What happened to Kiromic Biopharma, Inc.’s price movement after its last earnings report?
Kiromic Biopharma, Inc. reported an EPS of -$6.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.415%.
Which hedge fund is a major shareholder of Kiromic Biopharma, Inc.?
Currently, no hedge funds are holding shares in KRBP
---
Company Description
Kiromic Biopharma, Inc.
Kiromic BioPharma Inc is a bio-technology company. The company is a gene editing which utilizes artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology.
---
Technical Analysis
Adial Pharmaceuticals
―
Atossa Therapeutics
―
Cyclacel Pharmaceuticals
―
Plus Therapeutics
―
Theravance Biopharma
―
Xencor
―
---